Subcutaneous Delivery Of Methotrexate Is Associated With Improved Treatment Survival Compared To Oral Administration For The Initial Treatment Of Patients With Early Rheumatoid Arthritis

被引：0
|
作者：
Hazlewood, Glen S. [1 ]
Thorne, J. Carter [2 ]
Pope, Janet E. [3 ]
Xiong, Juan [4 ]
Boire, Gilles [5 ]
Haraoui, Boulos [6 ]
Hitchon, Carol A. [7 ]
Keystone, Edward C. [8 ]
Tin, Diane [2 ]
Bykerk, Vivian P. [9 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Southlake Reg Hlth Ctr, Newmarket, ON, Canada
[3] St Joseph Hlth Care, London, ON, Canada
[4] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[5] Univ Sherbrooke, CHU Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada
[6] Inst Rhumatol Montreal, Montreal, PQ, Canada
[7] Univ Manitoba, Winnipeg, MB, Canada
[8] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[9] Hosp Special Surg, Weill Cornell Med Coll, New York, NY 10021 USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1475
引用
收藏
页码：S627 / S627
页数：1
相关论文
共 50 条
  • [41] Treatment of rheumatoid arthritis with methotrexate in Congolese patients
    Malemba, J. J.
    Muamba, J. M. Mbuyi
    Mukaya, J.
    Bossuyt, X.
    Verschueren, P.
    Westhovens, R.
    CLINICAL RHEUMATOLOGY, 2013, 32 (09) : 1323 - 1327
  • [42] Nodules in patients with rheumatoid arthritis and methotrexate treatment
    Nakamura, Tadashi
    Inaba, Megumi
    Yoshinaga, Takeshi
    Takaoka, Hirokazu
    Iyama, Ken-ichi
    MODERN RHEUMATOLOGY, 2015, 25 (05) : 812 - 813
  • [43] Treatment of rheumatoid arthritis with methotrexate in Congolese patients
    J. J. Malemba
    J. M. Mbuyi Muamba
    J. Mukaya
    X. Bossuyt
    P. Verschueren
    R. Westhovens
    Clinical Rheumatology, 2013, 32 : 1323 - 1327
  • [44] Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
    Gerolamo Bianchi
    Roberto Caporali
    Monica Todoerti
    Paolo Mattana
    Advances in Therapy, 2016, 33 : 369 - 378
  • [45] Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
    Bianchi, Gerolamo
    Caporali, Roberto
    Todoerti, Monica
    Mattana, Paolo
    ADVANCES IN THERAPY, 2016, 33 (03) : 369 - 378
  • [46] Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial
    Hebing, Renske C. F.
    Lin, Marry
    Calasan, Maja Bulatovic
    Muller, Ittai B.
    Mahmoud, Sohaila
    Heil, Sandra
    Struys, Eduard A.
    van den Bemt, Bart J. F.
    Twisk, Jos W. R.
    Lems, Willem
    Nurmohamed, Michael T.
    Jansen, Gerrit
    de Jonge, Robert
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04) : 460 - 467
  • [47] Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate
    Strand, V
    Cohen, S
    Schiff, M
    Weaver, A
    Fleischmann, R
    Cannon, G
    Fox, R
    Moreland, L
    Olsen, N
    Furst, D
    Caldwell, J
    Kaine, J
    Sharp, J
    Hurley, F
    Loew-Friedrich, I
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) : 2542 - 2550
  • [48] Treatment of active rheumatoid arthritis with leflunomide compared to placebo or methotrexate
    Weaver, A
    Caldwell, J
    Olsen, N
    Cohen, S
    Strand, V
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S131 - S131
  • [49] IS SIDE EFFECTS AND TREATMENT RESPONSE TO METHOTREXATE ASSOCIATED TO COMORBIDITY IN EARLY RHEUMATOID ARTHRITIS
    Pedersen, K. L.
    Hallas, J.
    Hansen, I. M. J.
    Ahlquist, P.
    Ellingsens, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 592 - 592
  • [50] Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis
    Pincus, T
    Yazici, Y
    Sokka, I
    Aletaha, D
    Smolen, JS
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (05) : S179 - S185
12345